Asofarma S.A Prepares the First Batch of Rare Diseases Drug

In a significant move on February 28, the day before annual Rare Disease Day, Asofarma S.A announced the preparation of the first batch of Dilfcote, a pioneering treatment for a rare disease. This milestone underscores our commitment to addressing the needs of patients with rare conditions.

One Response to “Asofarma S.A Prepares the First Batch of Rare Diseases Drug

Leave a Reply

Your email address will not be published. Required fields are marked *